FDA Import Refusal AEK-2049233-5/50003/1 — CIPLA HEALTH LTD
The FDA refused shipment AEK-2049233-5/50003/1 from CIPLA HEALTH LTD (India) on Sep 3, 2026. The refused product falls under Drugs and Biologics — RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 3, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60SDB27 RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER)
- Charges
- 75